To broaden the evaluation of β-ARs as tumour targets in diverse human sarcomas, we prepared a short-term culture from the biopsy of an SFT male patient to determine β-AR expression and sensitivity to the β-adrenergic receptor antagonist propranolol. Here, CTBP1 is linked to sarcoma.